Literature DB >> 19550292

A proteomic study on a human osteosarcoma cell line Saos-2 treated with diallyl trisulfide.

Yong Kui Zhang1, Xu Hua Zhang, Jian Min Li, De Sheng Sun, Qiang Yang, Dong Mei Diao.   

Abstract

Garlic is generally used as a therapeutic reagent against various diseases, and numerous studies have indicated that garlic and its derivatives can reduce the risk of various types of human cancer. Diallyl trisulfide (DATS), a major member of garlic derivatives, could inhibit the cell proliferation by triggering either cell cycle arrest or apoptosis in a variety of cancer cell lines as shown in many studies. However, whether DATS has the same effect on human osteosarcoma cells remains unknown. In this study, we have attempted to analyze the effects of DATS on cell proliferation, cell cycle, induction of apoptosis, global protein expression pattern in a human osteosarcoma cell line Saos-2 cells, and the potential molecular mechanisms of the action of DATS. Saos-2 cells, a human osteosarcoma cell line, were treated with or without 25, 50, and 100 micromol/l DATS for various time intervals. The cell proliferation, cell cycle progression, and apoptosis were examined in this study. Then, after treatment with or without 50 micromol/l DATS for 48 h, protein add pattern in Saos-2 cells were systematically studied using two-dimensional electrophoresis and mass spectrometry. DATS could inhibit the proliferation of Saos-2 cells in a dose-dependent and time-dependent manner. Moreover, the percentage of apoptotic cell and cell arrest in G0/G1 phase was also dose-dependent and time-dependent upon DATS treatment. A total of 27 unique proteins in Saos-2 cells, including 18 downregulated proteins and nine upregulated proteins, were detected with significant changes in their expression levels corresponding to DATS administration. Interestingly, almost half of these proteins (13 of 27) are related to either the cell cycle or apoptosis. DATS has the ability to suppress cell proliferation of Saos-2 cells by blocking cell cycle progression and inducing apoptosis in a dose and time-dependent manner. The proteomic results presented, therefore, provide additional support to the hypothesis that DATS is a strong inducer of apoptosis in tumor cells. However, the exact molecular mechanisms, how these proteins significantly changed in the Saos-2 cell line upon DATS treatment, should be further studied.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19550292     DOI: 10.1097/CAD.0b013e32832e89c7

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  11 in total

1.  Opportunities and challenges for nutritional proteomics in cancer prevention.

Authors:  Donato F Romagnolo; John A Milner
Journal:  J Nutr       Date:  2012-05-30       Impact factor: 4.798

2.  Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway.

Authors:  Pan He; Zhijun Wang; Bin Sheng; Yongqiang Xu; Siyin Feng; Yan Huang; Fuqiang Gong; Liting Tang; Liming Xie
Journal:  Histol Histopathol       Date:  2020-12-29       Impact factor: 2.303

3.  Role of Bim in diallyl trisulfide-induced cytotoxicity in human cancer cells.

Authors:  Byeong-Chel Lee; Bae-Hang Park; Seog-Young Kim; Yong J Lee
Journal:  J Cell Biochem       Date:  2011-01       Impact factor: 4.429

Review 4.  Molecular mechanisms and targets of cancer chemoprevention by garlic-derived bioactive compound diallyl trisulfide.

Authors:  Marie Lue Antony; Shivendra V Singh
Journal:  Indian J Exp Biol       Date:  2011-11       Impact factor: 0.818

5.  In vitro efficacy of diallyl sulfides against the periodontopathogen Aggregatibacter actinomycetemcomitans.

Authors:  Kabilan Velliyagounder; Krishnaraj Ganeshnarayan; Senthil Kumar Velusamy; Daniel H Fine
Journal:  Antimicrob Agents Chemother       Date:  2012-02-13       Impact factor: 5.191

6.  Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell lines.

Authors:  Zhiyu Zhang; Lijun Zhang; Yingqi Hua; Xiaofang Jia; Jian Li; Shuo Hu; Xia Peng; Pengyuan Yang; Mengxiong Sun; Fang Ma; Zhengdong Cai
Journal:  BMC Cancer       Date:  2010-05-14       Impact factor: 4.430

7.  Proteomic technologies for the study of osteosarcoma.

Authors:  Stephanie D Byrum; Charity L Washam; Corey O Montgomery; Alan J Tackett; Larry J Suva
Journal:  Sarcoma       Date:  2012-03-06

8.  The synergistic effects of traditional Chinese herbs and radiotherapy for cancer treatment.

Authors:  Lili Jia; Shumei Ma; Xue Hou; Xin Wang; Abu Baker Layth Qased; Xuefei Sun; Nan Liang; Huicheng Li; Heqing Yi; Dejuan Kong; Xiaodong Liu; Feiyue Fan
Journal:  Oncol Lett       Date:  2013-03-12       Impact factor: 2.967

9.  Surface proteomic analysis of osteosarcoma identifies EPHA2 as receptor for targeted drug delivery.

Authors:  J Posthumadeboer; S R Piersma; T V Pham; P W van Egmond; J C Knol; A M Cleton-Jansen; M A van Geer; V W van Beusechem; G J L Kaspers; B J van Royen; C R Jiménez; M N Helder
Journal:  Br J Cancer       Date:  2013-09-24       Impact factor: 7.640

10.  Experimental study of inhibitory effects of diallyl trisulfide on the growth of human osteosarcoma Saos-2 cells by downregulating expression of glucose-regulated protein 78.

Authors:  Yue Zhang; Wen-Peng Xie; Yong-Kui Zhang; Yi-Qiang Chen; Dong-Li Wang; Gang Li; Dong-Hui Guan
Journal:  Onco Targets Ther       Date:  2018-01-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.